Interview with Walter Ricciardi, Professor of General and Applied Hygiene at the Catholic University, Advisor to the Italian government for Italy’s relationships with international health organisations. How was the Italian response to the spread of Covid-19 organised? From an institutional point of view, in Italy, there are two entities dealing with public health: the central ...
Interview on the Corona crisis with Professor Alexander Kekulé, virologist and epidemiologist. Prof. Kekulé is Director of the Institute for Biosecurity Research (IBS) and Director of the Institute for Medical Microbiology at Martin Luther University in Halle, Germany. Europe has become the epicentre of the Corona crisis — were governments too slow to act, and ...
As the COVID-19 pandemic continues, the need for reliable sources of information on the virus and ensuing crisis is more important than ever. To this end, the European Science-Media Hub has compiled a list of such sources, ranging from recognised official international webpages providing daily updates, to data and maps, as well as a selection ...
Social media platforms have taken a leading role in our everyday lives and have changed the way we obtain health information online. The most recent topic fueling disinformation is the novel Coronavirus. However, it is not the only one.
In the last days, an increasing number of COVID-19 cases has been confirmed in various countries around the world, e.g. South Korea and Iran. In the EU extraordinary measures are being taken to limit the outbreak. On 23 February, the ECDC issued a statement on the rapid increase of COVID-19 in Italy. On 24 Febuary, ...
At a time of dramatic news of widespread infections in China from the new corona virus, COVID-19, virologists in the top European institutes are intensively working to understand more about the novel disease.
A so-called ‘productivity crisis’ has been ascribed to the pharmaceutical research and development industry. Despite increases in investment and funding, this has not corresponded to increases in the approval of novel drugs. Why do so many drugs fail to receive approval, and what other means should we be focusing on for the benefit of patients?
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses AT Internet to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!